• Title/Summary/Keyword: pneumonia

Search Result 1,801, Processing Time 0.027 seconds

A Case of Acute Eosinophilic Pneumonia (급성 호산구성 폐렴 1예)

  • Lee, Ki-Hoon;Cho, Chul-Ho;Koh, Kwang-Kon;Moon, Tai-Hoon;Jang, Dong-Seob;Park, Chan-Sup;Kim, Jin-Joo;Kim, Joon-Mee
    • Tuberculosis and Respiratory Diseases
    • /
    • v.42 no.1
    • /
    • pp.99-104
    • /
    • 1995
  • Most cases of eosinophilic pneumonia reported previously have followed a chronic course. The case presented here was acute in onset, suggesting a acute eosinophilic pneumonia. A model of criteria for acute and chronic eosinophilic pneumonia was made by Umeki in 1992. A previously healthy young man presented with cough, sputum, fever, and multiple small nodules on the chest radiograph. We confirmed eosinophilic pneumonia with bronchoalveolar lavage analysis and transbronchial lung biopsy. This case examplifies the recently descrived acute eosinophilic pneumonia.

  • PDF

Case study: Selection of the weather variables influencing the number of pneumonia patients in Daegu Fatima Hospital (사례연구: 대구 파티마 병원 폐렴 입원 환자 수에 영향을 미치는 날씨 변수 선택)

  • Choi, Sohyun;Lee, Hag Lae;Park, Chungun;Lee, Kyeong Eun
    • Journal of the Korean Data and Information Science Society
    • /
    • v.28 no.1
    • /
    • pp.131-142
    • /
    • 2017
  • The number of hospital admissions for pneumonia tends to increase annually and even more, pneumonia, the fifth leading causes of death among elder adults, is one of top diseases in terms of hospitalization rate. Although mainly bacteria and viruses cause pneumonia, the weather is also related to the occurrence of pneumonia. The candidate weather variables are humidity, amount of sunshine, diurnal temperature range, daily mean temperatures and density of particles. Due to the delayed occurrence of pneumonia, lagged weather variables are also considered. Additionally, year effects, holiday effects and seasonal effects are considered. We select the related variables that influence the occurrence of pneumonia using penalized generalized linear models.

A Case of Dermatomyositis with Secondary Organizing Pneumonia (이차성 기질화 폐렴이 동반된 피부근염 1예)

  • Park, Chul-Yun;Chung, Jung-Seok;Chung, Jin-Wook;Lee, Choong-Ki;Hyun, Dae-Sung;Choe, Jung-Yoon
    • Journal of Yeungnam Medical Science
    • /
    • v.25 no.2
    • /
    • pp.117-123
    • /
    • 2008
  • Dermatomyositis is characterized by progressive, symmetric, proximal muscle weakness and a nonsuppurative inflammatory myopathy of unknown etiology involving predominantly skeletal muscles. It is also characterized by typical skin lesions. Interstitial lung disease has a poor prognosis when it is associated with dermatomyositis. Organizing pneumonia is a disease in which granulation tissue fills the lumina of terminal and respiratory bronchioles and extends into the distal airspaces. The cryptogenic nature of the process is appreciated in that organizing pneumonia patterns of injury can be seen in secondary forms of the disease (secondary organizing pneumonia). Organizing pneumonia has been reported to occur in 5~10% in dermatomyositis-polymyositis patients. Anti-histidyl tRNA synthetase antibody (anti-Jo-1) is a predictive disease marker that is reported to occur in up to 70% of patients. We describe a 49-year-old male dermatomyositis patient who presented with organizing pneumonia and was found to have negative anti-Jo-1 antibody.

  • PDF

Suitable Food Textures for Videofluoroscopic Studies of Swallowing in Esophageal Cancer Cases to Prevent Aspiration Pneumonia

  • Sonoi, Mika;Kayashita, Jun;Yamagata, Yoshie;Tanimoto, Keiji;Miyamoto, Ken-ichi;Sakurama, Kazufumi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.7
    • /
    • pp.3259-3263
    • /
    • 2016
  • Aims: To determine suitable food textures for videofluoroscopic study of swallowing (VFSS), in order to predict and prevent subsequent aspiration pneumonia in esophageal cancer patients with dysphagia after surgery. Materials and Methods: We evaluated 45 hospitalized esophageal cancer patients who underwent surgery between January 2012 and December 2013. The control group consisted of 43 patients treatmed from January 2010 until December 2011 and were not examined by VFSS. Test foods, which were presented in order of increasing thickness, included thin barium sulfate (Ba) liquid (3 or 10 ml), slightly thickened Ba liquid (3 or 10 ml), a spoonful of Ba jelly, and a spoonful of Ba puree. Results: Patients could most safely swallow puree, followed by jelly. The 3-mL samples of both the thin and thick liquids put patients at risk for aspiration pneumonia, with incidence rates of 13% and 11%, respectively. While 64.4% of patients could swallow all test foods and liquids safely, 35.6% were at risk for aspiration pneumonia when swallowing liquids. Even though >30% of patients were at risk, only 1 (2.2%) in the VFSS group developed aspiration pneumonia, which occurred at the time of admission. Following VFSS, no incidence of aspiration pneumonia was observed. However, aspiration pneumonia occurred in 4 (9.3%) control patients during hospitalization. Conclusions: Postoperative esophageal cancer patients were more likely to aspirate any kind of liquid than solid foods, such as jellies. VFSS is very useful in determining suitable food textures for postoperative esophageal cancer patients.

Laboratory Investigation of Trends in Bacterial Pneumonia in Cheonan, Korea, from January 2008 to September 2017

  • Yook, Young-Sam;Jeon, Jae-Sik;Park, Ji On;Kim, Jae Kyung
    • Journal of Microbiology and Biotechnology
    • /
    • v.28 no.10
    • /
    • pp.1730-1735
    • /
    • 2018
  • Bacterial pneumonia is one of the most common causes of mortality in Korea. In 2016, the mortality rate from pneumonia was 16,476 deaths per 100,000, which was an 11% increase from the previous year. The aim of our study was to determine the distribution of the bacterial pathogens causing respiratory symptoms in different age groups over a 10-year period. Between January 2008 and September 2017, 1,861 specimens from 1,664 patients admitted to Dankook University Hospital with respiratory symptoms were examined. We used multiplex polymerase chain reaction (PCR) to detect six bacterial pneumonia pathogens: Bordetella pertussis, Chlamydophila pneumoniae, Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Streptococcus pneumoniae. We detected bacterial pneumonia pathogens in 1,281 (68.83%) specimens. Of the 1,709 pathogens detected, S. pneumoniae was the most common (48.57%; n = 830) followed by H. influenzae (40.08%; n = 685). Most infections were found among children younger than 10 years (92.69%; n = 1,584). Although S. pneumoniae was the most common pathogen detected in all age groups, M. pneumoniae infection increased in prevalence with age (p < 0.05). The rate of co-infection was also high among these patients (31.1%; n = 399), which peaked in 2015 (54.55%; n = 42/77). The prevalence of bacterial pneumonia in Cheonan, along with the proportion of co-infections among patients increased over the 10-year study period. The findings will aid the development of treatment and prevention guidelines.

Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children

  • Yang, Hyeon-Jong;Song, Dae Jin;Shim, Jung Yeon
    • Clinical and Experimental Pediatrics
    • /
    • v.60 no.6
    • /
    • pp.167-174
    • /
    • 2017
  • Mycoplasma pneumoniae pneumonia (MPP) is one of the most common forms of community-acquired pneumonia in children and adolescents. Outbreaks of MPP occur in 3- to 7-year cycles worldwide; recent epidemics in Korea occurred in 2006-2007, 2011, and 2015-2016. Although MPP is known to be a mild, self-limiting disease with a good response to macrolides, it can also progress into a severe and fulminant disease. Notably, since 2000, the prevalence of macrolide-resistant MPP has rapidly increased, especially in Asian countries, recently reaching up to 80%-90%. Macrolide-resistant Mycoplasma pneumoniae (MRMP) harbors a point mutation in domain V of 23S rRNA with substitutions mainly detected at positions 2063 and 2064 of the sequence. The excessive use of macrolides may contribute to these mutations. MRMP can lead to clinically refractory pneumonia, showing no clinical or radiological response to macrolides, and can progress to severe and complicated pneumonia. Refractory MPP is characterized by an excessive immune response against the pathogen as well as direct injury caused by an increasing bacterial load. A change of antibiotics is recommended to reduce the bacterial load. Tetracyclines or quinolones can be alternatives for treating MRMP. Otherwise, corticosteroid or intravenous immunoglobulin can be added to the treatment regimen as immunomodulators to downregulate an excessive host immune reaction and alleviate immune-mediated pulmonary injury. However, the exact starting time point, dose, or duration of immunomodulators has not been established. This review focuses on the mechanism of resistance acquisition and treatment options for MRMP pneumonia.

Recurrent Desquamative Interstitial Pneumonia with Fibrotic Lung Disease (폐섬유화를 동반한 재발성 박리성 간질성 폐렴)

  • Kim, Won Jin;Choi, Jeong Hee;Park, Yong Bum;Cho, Sung Woo;Nam, Eun Sook;Mo, Eun Kyung
    • Tuberculosis and Respiratory Diseases
    • /
    • v.65 no.4
    • /
    • pp.328-333
    • /
    • 2008
  • Desquamative interstitial pneumonia is an uncommon form of interstitial lung diseases and it has a good prognosis compared with other types of idiopathic interstitial pneumonia. A 69-year old man was admitted to our hospital because of a 3-month history of dyspnea. The patient presented with hypoxemia. High-resolution computerized tomography of the patient showed ground glass opacity and traction bronchiectasis with subpleural early honeycombing on the both lung fields. The pathologic findings of the video-assisted thoracoscopy lung biopsy were compatible with desquamative interstitial pneumonia, and irregularly distributed interstitial fibrosis and inflammation were observed at the peripheral parenchyme. Oral predinsolone was started; his symptoms and chest x-ray were improved, and so he stopped taking the prednisolone. Ten months later, the desquamative interstitial pneumonia recurred. We report here on a case of recurrent desquamative interstitial pneumonia with fibrotic lung disease.

A Case of Lipoid Pneumonia Induced by Aspiration of Shark Liver Oil (상어 간유 흡인에 의한 지방성 폐렴 1예)

  • Lee, Jin-Suk;Ju, Hong-Don;Han, Chang-Wan;Lee, Gwi-Lae;Cho, Yung-Sam;Park, Un-Slk;Jeong, Dong-Seong;Han, Jong-Hak;Kim, Jae-Hong;Son, Yong-Woo;Roh, Yong-Ho;Kim, Jeong-Lae
    • Tuberculosis and Respiratory Diseases
    • /
    • v.41 no.6
    • /
    • pp.670-675
    • /
    • 1994
  • Lipoid pneumonia is a chronic inflammatory reaction of the lungs that results from the aspiration of vegetable, animal, or mineral oils. The most frequently implicated agent is mineral oil used as a laxative and to reduce dysphagia. Lipoid pneumonia is suggested when there is a history of chronic oral or intranasal use of an oil- or lipid-based product. The characteristic findings of lipid materials in CT or MRI are used in the diagnosis of lipoid pneumonia. The presence of lipid-laden macrophages in the sputum, bronchoalveolar larvage or pulmonary parenchymal biopsy confirms the diagnosis. Sputum study is simple and inexpensive. We report a case of lipoid pneumonia of 75 year old male with cough and sputum, confirmed by sputum study, and review the literature.

  • PDF

A Case of Acute Intersitial Pneumonia (급성 간질성 폐렴 1예)

  • Ahn, Young-Soo;Rha, Dong-Jib;Lee, Sang-Moo;Kim, Hyeon-Tae;Uh, Soo-Taek;Kim, Yong-Hoon;Park, Choon-Sik;Park, Jae-Soung;Choi, Deuk-Lin;Jin, So-Young;Lee, Dong-Wha
    • Tuberculosis and Respiratory Diseases
    • /
    • v.40 no.6
    • /
    • pp.719-724
    • /
    • 1993
  • There is a small portion of interstitial pneumonia which presents acute respiratory failure developing within several days. The course of illness is short and most patients die within weeks or months. This type of interstitial pneumonia has been variously termed Hamman-Rich syndrome, accelerated interstitial pneumonia, or the organizing stage of diffuse alveolar damage. We experienced a case of acute interstitial pneumonia in 42-year old female who showed clinical, radiological and histologic features of acute interstitial pneumonia without any identified etiologic agent.

  • PDF

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children

  • Ha, Seok Gyun;Oh, Kyung Jin;Ko, Kwang-Pil;Sun, Yong Han;Ryoo, Eell;Tchah, Hann;Jeon, In Sang;Kim, Hyo Jeong;Ahn, Jung Min;Cho, Hye-Kyung
    • Journal of Korean Medical Science
    • /
    • v.33 no.43
    • /
    • pp.268.1-268.11
    • /
    • 2018
  • Background: We aimed to compare the therapeutic efficacy of prolonged macrolide (PMC), corticosteroids (CST), doxycycline (DXC), and levofloxacin (LFX) against macrolide-unresponsive Mycoplasma pneumoniae (MP) pneumonia in children and to evaluate the safety of the secondary treatment agents. Methods: We retrospectively analyzed the data of patients with MP pneumonia hospitalized between January 2015 and April 2017. Macrolide-unresponsiveness was clinically defined with a persistent fever of ${\geq}38.0^{\circ}C$ at ${\geq}72$ hours after macrolide treatment. The cases were divided into four groups: PMC, CST, DXC, and LFX. We compared the time to defervescence (TTD) after secondary treatment and the TTD after initial macrolide treatment in each group with adjustment using propensity score-matching analysis. Results: Among 1,165 cases of MP pneumonia, 190 (16.3%) were unresponsive to macrolides. The proportion of patients who achieved defervescence within 48 hours in CST, DXC, and LFX groups were 96.9% (31/33), 85.7% (12/14), and 83.3% (5/6), respectively. The TTD after initial macrolide treatment did not differ between PMC and CST groups (5.1 vs. 4.2 days, P = 0.085), PMC and DXC groups (4.9 vs. 5.7 days, P = 0.453), and PMC and LFX groups (4.4 vs. 5.0 days, P = 0.283). No side effects were observed in the CST, DXC, and LFX groups. Conclusion: The change to secondary treatment did not show better efficacy compared to PMC in children with macrolide-unresponsive MP pneumonia. Further studies are needed to guide appropriate treatment in children with MP pneumonia.